Paysign (NASDAQ:PAYS) Stock Price Up 3.8% - Should You Buy?

Key Points

• Paysign shares rose 3.8% to about $14.90, bringing the stock’s market capitalization to approximately $836 million. The move occurred on trading volume well below its average.
• Analysts maintain a consensus “Buy” rating with an average price target of $15.00, while recent firms raised targets to that level. Paysign also exceeded quarterly expectations, reporting $0.11 in EPS versus the $0.06 consensus and revenue of $28.25 million.
• Insiders sold 444,904 shares worth about $5.3 million over the last quarter, although insiders still own 24.5% of the company. Institutional ownership stands at 25.89%, with several major investors increasing or initiating positions.

Paysign, Inc. (NASDAQ:PAYS - Get Free Report) shares shot up 3.8% during mid-day trading on Wednesday. The stock traded as high as $14.79 and last traded at $14.9010. 154,524 shares were traded during mid-day trading, a decline of 78% from the average session volume of 712,919 shares. The stock had previously closed at $14.36.

Analyst Ratings Changes

Several brokerages recently commented on PAYS. Wall Street Zen lowered shares of Paysign from a "strong-buy" rating to a "buy" rating in a research report on Sunday, August 16th. Barrington Research set a $15.00 price objective on shares of Paysign in a research note on Tuesday, August 11th. Weiss Ratings upgraded Paysign from a "hold (c+)" rating to a "buy (b-)" rating in a report on Wednesday, July 29th. Lake Street Capital increased their target price on Paysign from $13.00 to $15.00 and gave the stock a "buy" rating in a research report on Tuesday, September 15th. Finally, DA Davidson lifted their target price on Paysign from $12.00 to $15.00 and gave the company a "buy" rating in a report on Wednesday, September 30th. Three analysts have rated the stock with a Buy rating, According to MarketBeat.com, the company presently has a consensus rating of "Buy" and an average price target of $15.00.

Paysign Stock Up 3.1%

The firm's 50 day simple moving average is $12.63 and its 200-day simple moving average is $8.90. The company has a market capitalization of $836.17 million, a PE ratio of 57.04 and a beta of 0.83.

Paysign (NASDAQ:PAYS - Get Free Report) last issued its earnings results on Wednesday, August 5th. The company reported $0.11 EPS for the quarter, beating analysts' consensus estimates of $0.06 by $0.05. Paysign had a net margin of 15.67% and a return on equity of 30.13%. The business had revenue of $28.25 million for the quarter, compared to the consensus estimate of $26.36 million. Paysign has set its FY 2026 guidance at 0.350-0.370 EPS and its Q3 2026 guidance at 0.090-0.100 EPS. As a group, sell-side analysts anticipate that Paysign, Inc. will post 0.58 EPS for the current fiscal year.

Insider Buying and Selling

In other news, CFO Jeffery Baker sold 35,000 shares of Paysign stock in a transaction that occurred on Wednesday, August 12th. The shares were sold at an average price of $12.62, for a total transaction of $441,700.00. Following the sale, the chief financial officer owned 542,171 shares in the company, valued at $6,842,198.02. This trade represents a 6.06% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, EVP Joan M. Herman sold 38,900 shares of the business's stock in a transaction on Wednesday, September 16th. The stock was sold at an average price of $11.74, for a total transaction of $456,686.00. Following the transaction, the executive vice president directly owned 609,421 shares in the company, valued at approximately $7,154,602.54. The trade was a 6.00% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders sold 444,904 shares of company stock valued at $5,328,124. Insiders own 24.50% of the company's stock.

Hedge Funds Weigh In On Paysign

Institutional investors have recently added to or reduced their stakes in the company. Dimensional Fund Advisors LP grew its stake in Paysign by 16.8% during the 1st quarter. Dimensional Fund Advisors LP now owns 575,619 shares of the company's stock valued at $3,396,000 after purchasing an additional 82,736 shares in the last quarter. Bank of America Corp DE raised its position in shares of Paysign by 345.9% in the 1st quarter. Bank of America Corp DE now owns 130,930 shares of the company's stock valued at $772,000 after purchasing an additional 101,568 shares in the last quarter. Renaissance Technologies LLC boosted its stake in shares of Paysign by 17.4% during the 1st quarter. Renaissance Technologies LLC now owns 1,531,072 shares of the company's stock valued at $9,033,000 after buying an additional 227,300 shares during the last quarter. OneDigital Investment Advisors LLC acquired a new stake in shares of Paysign during the second quarter worth approximately $877,000. Finally, BlackRock Inc. acquired a new stake in shares of Paysign during the second quarter worth approximately $25,219,000. Institutional investors and hedge funds own 25.89% of the company's stock.

About Paysign

Paysign, Inc NASDAQ: PAYS provides prepaid payment and financial technology solutions, with a focus on healthcare, pharmaceutical and other specialized markets. Its platform supports the issuance and management of prepaid cards, digital payments, account services and related payment-processing activities.

The company's healthcare offerings include patient assistance and copay programs that help pharmaceutical manufacturers distribute financial support to eligible patients. Paysign also provides payment and card solutions for plasma collection centers, including programs used to compensate plasma donors.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.